Trials / Completed
CompletedNCT02230449
Identifying Expression Markers of Cumulus Cells to Identify Oocyte Developmental Potential Through a Maturation Analysis
Identifying Markers of Oocyte Competence Through a Maturation Analysis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (actual)
- Sponsor
- Memorial Sisli Hospital, Istanbul · Academic / Other
- Sex
- Female
- Age
- 18 Years – 39 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to analyze the expression of genes and microRNAs potentially involved in oocyte competence in follicles of different sizes (\<17mm and ≥17mm) at the time of oocyte pick-up.
Detailed description
In ART, one of the major obstacles encountered in some patients is the wide variation in the follicular size at the oocyte pick-up day and consequently, the number of available mature oocytes and the number of competent embryos for implantation. The follicular size at the day of oocyte pick-up reflects the synchronicity of the individual follicular responsiveness to FSH. For successful preimplantation development of an embryo, the oocyte must contain all necessary maternal factors. Two of these factors are specific mRNA transcripts (GDF9, PTX3, HAS2, PTGS2, TNFAIP6) and microRNA (miR-224). For each Cumulus Oocyte Complex, the evaluation of embryo development and morphokinetics will be correlated with the expression and implantation data to identify a quantitative biomarker to predict the embryo with the highest chance of implantation in patients. Experimental Design: 1. \- Collection of Cumulus Oocyte Complex (COC) from patients 2. \- Separation of oocytes according to the size of the follicule they have been retrieved from (\<17mm; ≥17mm) 3. \- Isolation of mRNA from both groups of cumulus cells 4. \- Expression studies, qRT-PCR (GDF9, PTX3, HAS2, PTGS2, TNFAIP6) 5. \- Analysis of miR-224, a negative regulator of cumulus expansion via PTX3 6. \- Time-lapse culture \& evaluation of morphokinetics
Conditions
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2016-06-01
- Completion
- 2016-09-01
- First posted
- 2014-09-03
- Last updated
- 2017-09-05
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT02230449. Inclusion in this directory is not an endorsement.